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1. Introduction 
The production of Shiga toxins (Verotoxins) is a characteristic trait of some strains of 
Escherichia coli. Shiga toxin-producing Escherichia coli (STEC), also called Verotoxin- 
producing E. coli (VTEC), were first described by Konowalchuk et al. in 1977 by their 
cytotoxic activity on African green monkey kidney (Vero) cells (Konowalchuk et al. 1977). 
STEC of serotype O157:H7 were linked to cases of Haemorrhagic Colitis (HC) and to the 
consumption of STEC- contaminated meat of bovine origin for the first time in 1982 
(Karmali et al. 2010; Riley et al. 1983). Since 1982, hundreds of outbreaks of disease caused 
by STEC O157 and non-O157 strains have been reported in different countries and 
geographical regions of the world. A growing number of genetic variants of Shiga toxins 1 + 
2 (Stx1 and Stx2) were identified and today more than 400 serotypes of E. coli strains isolated 
from human patients were found associated with Stx production (Scheutz and Strockbine 
2005). 
Some STEC serogroups such as O157, O26, O103, O111 and O145 were most frequently 
associated with outbreaks and with Haemorrhagic Colitis and Haemolytic Uraemic 
Syndrome (HUS) in human patients worldwide. Accordingly, these strains were designated 
as Enterohaemorrhagic E. coli (EHEC) (Nataro and Kaper 1998). Classical EHEC belonging 
to these serotypes are responsible for more than 80% of HUS cases in Europe and in the 
United States (Brooks et al. 2005; Eblen 2007; EFSA 2007; Karmali et al. 2003). As EHEC O157 
was reported to be the most frequent and virulent EHEC type a number of diagnostic tools 
(indicator media, O157 antigen detection kits, specific O157 enrichment media and O157- 
specific PCRs) have been developed for its specific identification (Frank et al. 2011). 
However, the recent outbreak of Enteroaggregative Haemorrhagic E. coli (EAHEC) E. coli 
O104:H4 in Germany indicates that serotypes other than O157 can suddenly become the 
most highly virulent human pathogens (Frank et al. 2011). 
Healthy dairy and beef cattle are recognized as a major natural reservoir of EHEC and other 
STEC strains. There are more than 100 serotypes of STEC which have been also isolated 
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from other animals such as sheep, pigs, goats, deer, horses, dogs and birds (Gyles 2007). 
Humans become infected most frequently by consuming STEC-contaminated food of 
different kinds, but also waterborne infections and the direct transmission from STEC-
excreting animals or humans are frequent (Caprioli et al. 2005). By contrast, humans but not 
animals were identified as the reservoir for the newly emerging EAHEC O104:H4 strain 
(ECDC et al. 2011). Studies have shown that STEC infections are more frequent in the 
warmer months and that the serotypes that are implicated may vary from country to 
country (Beutin 2006; Gyles 2007). 
2. Genetic and functional diversity of Shiga toxins 
The Shiga toxin family consists of two major groups, Shiga toxin 1 (Stx1) and Shiga toxin 2 
(Stx2). Shiga toxins are composed of two subunits. The active toxin subunit A (N-
glycosidase 32-KDa) is linked to five B-subunits as a pentamer (7.7-kDa monomers). The 
toxin subunit B is responsible for binding the toxin to GB3 or GB4 receptors on the 
eukaryotic cells. Stx1 and Stx2 are immunologically not cross-reactive and show themselves 
to be 55% different in their amino acid sequences (Muthing et al. 2009). A number of genetic 
variants were identified within the Stx1 and the Stx2 toxin families (Burk et al. 2003; Leung 
et al. 2003; Muthing et al. 2009). The variants differ in the amino-acid substitutions in their 
StxA and StxB subunits, which can have an influence on their toxicity and receptor-binding 
specificity (Muthing et al. 2009). The Stx1 group has been divided into the subtypes Stx1, 
Stx1a, Stx1c and Stx1d (Burk et al. 2003) (Figure 1).  
Stx1 is produced by some species of Shigella (Scheutz and Strockbine 2005). Stx1a is 
frequently found in STEC from cattle and in food of bovine origin (Martin and Beutin 2011) 
and it is found in major EHEC strains causing HC and HUS in humans. Stx1c was found to 
be associated with non-bloody diarrhoea in humans and is frequent in STEC from goats, 
sheep and red deer (Friedrich et al. 2003; Martin and Beutin 2011).  
 
Fig. 1. Genetic distances within the group of Stx1 family toxins 
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The Stx2 branch splits into the subgroups Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f and Stx2g 
(Persson et al. 2007) (Figure 2).  
The infection of humans with STEC-producing toxin variants Stx2a, Stx2c and Stx2d-
(activatable) was associated with an increased risk of developing HC and HUS, while STEC-
producing Stx1c, Stx2b and Stx2f were found to be more associated with uncomplicated 
cases of diarrhoea or with asymptomatic infections (Friedrich et al. 2002; Persson et al. 2007). 
Stx1d- and Stx2g-producing STEC have been isolated from animals and food but the 
possible role of these toxins in human disease needs to be confirmed (Beutin et al. 2007a; 
Kuczius et al. 2004; Miko et al. 2009). Humans are rarely infected with Stx2e-producing 
strains (Friedrich et al. 2002). STEC-producing Stx2e are linked to pigs as a hosts and are 
agents of oedema disease in pigs. Aside from Stx2e, these strains frequently produce heat-
stable and heat-labile enterotoxins and Stx2e has not been shown to play a role as a 
virulence marker for humans (Beutin et al. 2008).  
 
Fig. 2. Genetic distances within the group of Stx2 family toxins 
The Shiga toxin genes are encoded by lambdoid bacteriophages which are integrated into 
the bacterial chromosome by lysogenization where they remain present as prophages 
(Schmidt 2001). Some kinds of physico-chemical stress can trigger a cascade reaction called 
bacterial “SOS response” leading to the transcription of the prophage genome, resulting in 
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the production of both Shiga toxins and phage particles. The release of phages by bacterial 
lysis leads to the infection of new E.coli hosts and the generation of new STEC strains 
(Herold et al. 2004).  
3. Diagnosis of STEC by detection of Shiga toxins 
A number of indicator media for the identification of some STEC strains and types have 
been developed, as well as immunological, genetic and cell culture toxicity assays for Stx-
detection. The detection of Shiga toxins is the only way to identify all members of the STEC 
group which consists of strains with different phenotypes and serotypes (Bettelheim and 
Beutin 2003). The Vero cell toxicity assay (VCA) is used as a gold standard for detection of 
Stx production as it is the most sensitive. However, its specificity must be confirmed in 
neutralization assays with antisera directed against Stx. As the VCA is laborious, time-
consuming and demands a specifically designed laboratory and specially trained personnel 
there is a need for STEC detection systems which are rapid, reliable, standardized and easy 
to employ. Almost all STEC testing methods screen for Stx production with commercial 
serological assays or the presence of stx-genes is detected using PCR or DNA-hybridization 
assays (Paton and Paton 2003). 
Some STEC strains that were identified by stx-specific PCR failed to show serological 
reactivity in immunological detection systems for Stx (Beutin et al. 2007; Beutin et al. 2008). 
The lack of an Stx phenotype (serologically or cytotoxic) in a strain that tests positive when 
using stx-specific PCR may have several causes such as defective stx-genes, the absence of 
Stx expression, or the amount of Stx produced being below the detectable level of the given 
serological or cytological assay. Commercially-obtainable serological assays (EIA, RPLA) for 
Stx were found to vary greatly in their sensitivity (Bettelheim and Beutin 2003; Beutin et al. 
2007; Beutin et al. 2010; Beutin et al. 1996; Beutin et al. 2002; Beutin et al. 2008; Feng et al. 
2011; Jahn et al. 2008; Willford et al. 2009), and some STEC strains were found to produce 
low amounts of Stx, that were not detectable by tissue culture or serological tests. Previous 
work showed that about 1% of strains that carry stx-genes showed no production of Stx in 
the VCA as a gold standard (Beutin et al. 2007). A lack of Stx expression or low expression 
was found to be more frequent among certain stx-subtypes such as stx2b, stx2e and stx2g 
(Beutin et al. 2007; Beutin et al. 2007a; Beutin et al. 2008). Another possible cause of these 
discrepancies between the presence of stx-genes and the absence of Stx production may be 
caused by the specificity of anti-Stx antibodies or stx PCR primers used for the identification 
of the various Stx subtypes (Feng et al. 2011). 
Efforts to find reliable, specific and rapid methods for the detection of STEC have been 
increased over the last decades. Media containing inducing agents such as mTSB with 
Mitomycin C were used to trigger Stx production by bacteria for detection (Beutin et al. 
2008; Klie et al. 1997; Shimizu et al. 2009). Some antibiotics such as trimethoprim-
sulfamethoxazole and ciprofloxacin were found to enhance Stx production by bacteria and 
may increase the risk of HUS when used as therapeutic agents in human infections with 
STEC (McGannon et al. 2010; Wong et al. 2000).  
The detection of STEC can cause problems if food or clinical, animal and environmental 
samples that contain a mixture of different microorganisms are examined. Specific 
enrichment media are used for the recovery of injured STEC strains, which are often present 
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in food and environmental samples. The bacteria may be stressed during the processing and 
storage of food. The enrichment procedure provides an optimal growth medium and a 
period of time that can be effectively used, allowing the resuscitation of the bacterial cells 
(Hussein and Bollinger 2008). The detection of stressed STEC from samples depends largely 
on the choice of the cultivation media and conditions. Non-selective media such as buffered 
peptone water were found to be advantageous for the resuscitation of damaged STEC from 
various samples (Hussein and Bollinger 2008; Jahn and Beutin 2009).  
Stx detection kits such as enzyme-linked immunoassays (EIA) have been commercialized 
and are widely used as standardized assays in diagnostic laboratories. The evaluation of 
commercially available diagnostic test kits for Stx by E. coli reference laboratories has been 
shown to be valuable for the assessment of their specificity and sensitivity. In this work, we 
have evaluated an immuno-chromatographic lateral flow test for the detection of Shiga 
toxins and the E. coli O157 antigen which recently came on the market.  
4. Principle of the immuno-chromatographic lateral flow test system and test 
procedure 
The introduction of immuno-chromatographic lateral flow test systems has made Stx 
detection even quicker and simpler to perform than with the classical ELISA test. A specific 
photometer (ELISA-reader) is not necessary and the results are recorded by eye after 15 
minutes. A new development allowing the simultaneous detection of Stx-production and of 
the O157 antigen (as the most important EHEC type) is the commercially available “RIDA 
Quick” test (RIDA® QUICK Verotoxin/O157 Combi, R-biopharm AG, Darmstadt, 
Germany).  
The assay is bound to a plastic stick which is introduced with its absorbent end into the 
liquid sample containing Stx and O157 LPS as antigens. The principle of this assay is a 
single-step immuno-chromatographic lateral-flow test, where specific antibodies directed 
towards both target antigens are attached to red (Shiga toxin-specific) or green (O157-
specific) latex particles. Other specific antibodies against the two antigens are firmly 
attached to the membrane.  
Modified Tryptic Soy Broth (mTSB) containing Mitomycin C (Klie et al. 1997) is inoculated 
with the test strain or sample and incubated at 37°C for 18 to 24 hours for the production of 
Shiga toxin. Mitomycin C serves as an enhancer to stimulate Stx-production and release in 
the culture fluid. After growth, the sample is centrifuged (1500g for 15 minutes) and 1 ml of 
the supernatant fluid is diluted 1:1 with a sample buffer (part of the test system). The 
mixture is used directly for the test. The RIDA-QUICK test stick is placed into the test 
sample and the reaction occurs by the lateral flow of specific antibodies bound to coloured 
latex particles. Antibodies bind themselves to specific antigens (Stx and/or O157 LPS) if 
present in the sample and the antigen-antibody complex flows via the membrane to specific 
collection bands where they are fixed by immobilized, specific antibodies. A green (O157 
LPS) and/or red (Stx) band becomes visible if these antigens are present in the sample. The 
test does not differentiate between Stx1 and Stx2. A blue band is always shown as a control. 
The coloured bands become visible after 15 minutes and the strength of the reaction is rated 
between 0 (not visible) and 4+ (maximum colour development), according to colour 
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intensity (Figure 3). A description is provided by the producer and the assay was performed 
accordingly (http://www.r-biopharm.de/). 
 
Fig. 3. Detection of Stx production and the O157 antigen from enrichment cultures of salad 
samples inoculated with different quantities of EHEC O157 strain EDL933. 
5. Results 
5.1 Evaluation of the RIDA®QUICK Verotoxin/O157 Combi (Rida Quick) test with 
Shigella and E. coli reference strains 
We have evaluated the RIDA Quick test for its sensitivity and specificity with all the known 
variants of Stx1 and Stx2. For the evaluation, we employed STEC references strains for the 
different Stx-types and subtypes together with STEC isolates from food and other sources 
that were previously characterized at the NRL-E.coli at the BfR (Beutin et al. 2007a; Miko et 
al. 2009). The RIDA Quick was compared for its sensitivity and specificity with the 
Ridascreen® Verotoxin enzyme immunoassay (R-Biopharm, Darmstadt, Germany), and Stx-
specific ELISA which was evaluated previously (Beutin et al. 2007). The Vero cell toxicity 
test was used as a gold-standard for toxin activity. 
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In total, two strains of Shigella dysenteriae and S. sonnei (Stx1) and 18 E. coli-producing toxins 
of the Stx1 family (Stx1 (n=2), Stx1a (n=9), Stx1c (n=5) and Stx1d (n=4) were tested. The 
RIDA Quick detected all strains of the Stx1 family (sensitivity of 100%). All the reactions 
were 4+, except for Stx1d strains showing reaction intensities between 1+ and 3+. Similar 
results were obtained with the Ridascreen-Stx-EIA (Beutin et al. 2007, this work). 
Fifty-five strains were tested as representatives of the Stx2 family. The results were very 
good for the Stx2a (12/12 positive) and Stx2c (6/6 positive). Stx2b, formerly called Stx2d 
non-activatable (Pierard et al. 1998) was detected in 8 of 9 strains tested (88.9 %). The mucus-
activatable Stx2d (Melton-Celsa et al. 2002) was detected in 5 of 7 positive strains (71.4 %). 
The Stx2e variant was detected in only 3 of 11 Stx2e strains (27.3%) and Stx2g in only 1 of 4 
positive strains (25%). The Stx2f variant was not detected in any of the six Stx2f-producing 
strains that were tested. Thirty-three strains producing multiple types of Stx strain were all 
detected. Four Stx-negative strains were used as controls and false positive reactions were 
not recorded (Table 1). The results obtained with the Rida Screen Verotoxin ELISA were 
identical to those obtained with the RIDA Quick Test for Stx-detection (Table 1). 
 
   Numbers of strains testing positive for Stx 
numbers 
of strains 
bacterial 
species 
Stx type 
by stx-PCR and 
Verocellassay 
by Rida Sccreen and 
by Rida Quick (%) 
1 S. dysenteriae Stx1 1 (100) 1 (100) 
1 S. sonnei Stx1 1 (100) 1 (100) 
9 E. coli Stx1a 9 (100) 9 (100) 
5 E. coli Stx1c 5 (100) 5 (100) 
4 E. coli Stx1d 4 (100) 4 (100) 
12 E .coli Stx2a 12 (100) 12 (100) 
6 E. coli Stx2c 6 (100) 6 (100) 
9 E. coli Stx2b 9 (100) 8 (88.9) 
7 E. coli Stx2d 7 (100) 5 (71.4) 
11 E. coli Stx2e 11 (100) 3 (27.3) 
4 E. coli Stx2g 4 (100) 1 (25.0) 
6 E. coli Stx2f 6 (100) 0 (0) 
33 E. coli multiple 33 (100) 33 (100) 
4 E. coli none 0 (0) 0 (0) 
Table 1. Types of Stx tested and their percentages detected by Rida Screen Verotoxin Elisa 
and Immuno-chromotographic RIDA quick. 
5.2 Detection of the O157 antigen 
The specificity of the assay for the E. coli O157 antigen was tested with 134 strains belonging 
to 45 different O-antigen groups of E. coli, including 17 E. coli O157 strains. The RIDA Quick 
assay detected all E. coli O157 strains tested, irrespective of whether these were STEC or not. 
Strains belonging to the non-O157 serogroups did not react for the O157 antigen in the Rida 
Quick assay indicating a specificity of 100%.  
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5.3 Detection of Stx- and the O157 antigens from EHEC-contaminated food samples  
The sensitivity of the Rida Quick test for detection of Stx and the O157 antigen was analyzed 
for food samples spiked with different amounts of EHEC strains. Twenty-five-gram 
portions of retailed ready-to-eat salads were inoculated with different amounts (<10, 10-100, 
100-1000 cfu) with different concentrations of EHEC reference strains belonging to 
serogroups O26, O103, O111, O145, O157 (Table 2).  
 
  Numbers of  EHEC per 25g salad sample inoculated 
  none ≤10 10-100 100-1000 
EHEC-
serotype 
Stx-Type 
Rida 
screena
Rida-
Quick
Rida-
Screen
Rida-
Quick
Rida-
Screen
Rida-
Quick
Rida-
Screen 
Rida-
Quick 
O157:H7b Stx1a + Stx2a 0.015 - 3.448 4+ 9.992 4+ 9.992 4+ 
O26:H11 Stx1a 0.001 - 0.727 3+ 2.655 4+ 9.993 4+ 
O103:H2 Stx1a 0.015 - 9.983 4+ 9.983 4+ 9.983 4+ 
O145:H28 Stx2a 0.003 - 2.932 4+ 3.475 4+ 3.402 4+ 
O111:H8 Stx1a 0.001 - 3.269 4+ 3.303 4+ 9.995 4+ 
O118:H16 Stx2a 0.007 - 9.986 3+ 9.986 4+ 9.986 4+ 
O121:H19 Stx2a 0.007 - 2.911 4+ 3.479 4+ 3.278 4+ 
a) Extinction values at OD450 nm for the Rida Screen were calculated as described previously (Beutin et 
al. 2007) b) the O157 antigen was detected as 4+ in all concentrations with the Rida-Quick test 
Table 2. Detection of Shiga toxins produced by EHEC strains from spiked ready-to-eat salad 
samples.  
Spiked and unspiked control 25 g salad samples were each homogenized in 225 ml BRILA-
Broth and the homogenates were grown aerobically for six hours at 37°C for EHEC 
enrichment (Tzschoppe 2010). After, 1 ml of BRILA broth enrichment culture was inoculated 
into 5ml of mTSB + Mitomycin (Klie et al. 1997) and incubated at 37°C for a further 18 hours. 
The mTSB+ Mitomycin C cultures were examined for the presence of Stx and O157 antigens 
with the Rida Screen and the Rida Quick assay. Unspiked salad samples were taken as 
negative controls. In all the spiked salad samples tested we detected positive reactions 
(Table 2). No false positive reaction was found. The results obtained with O157:H7-
inoculated salad samples are shown in Figure 3.  
6. Discussion 
The RIDA Quick was found suitable for the routine screening of bacterial isolates and for 
the detection of all Stx subtypes tested, except for Stx2f. All other Stx-variants were easily 
detectable with this assay. Negative Stx detection results obtained for some Stx2b, Stx2d, 
Stx2e and Stx2g strains are probably due to the poor Stx production, which is below the 
detectable level for the serological assays.  
The results obtained with the Rida Screen Verotoxin ELISA were identical to those obtained 
with the RIDA Quick Test for Stx-detection (Table 1). As both tests are from the same 
producer, it is possible that the antibodies used for Stx detection are the same in both assays.  
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All Stx types except Stx2f were detectable with the RIDA Quick assay and the Rida Screen 
ELISA. Stx2f is genetically the most distant from all other toxins of the stx2 group (Persson 
et al. 2007; Schmidt et al. 2000). It is therefore possible that the Stx2-specific antibody used 
for the RIDA Quick and the RidaScreen assay does not react with the Stx2f variant toxin. 
The nucleotide sequence of Stx2f is sufficiently divergent (Fig. 2) that it is not detected by 
many Stx2-specific PCR primers (Schmidt et al. 2000), nor in Real time Stx- detection kits for 
Stx2 (Beutin et al. 2009). Some Stx2b, Stx2d, Stx2e and Stx2g strains did not produce enough 
toxins to be detectable by both Rida Screen and RIDA Quick (Beutin et al. 2007; Beutin et al. 
2007a; Beutin et al. 2008). The Stx types Stx1, Stx2a and Stx2c that are associated with typical 
EHEC strains (Nataro and Kaper 1998) were detected in all the tested strains.  
The first results with EHEC inoculated food samples indicate that the RIDA Quick assay is 
suitable for the screening of food samples such as ready-to-eat salads. These kinds of 
vegetable food samples are characterized by their high level of contamination (106-107 cfu / 
g) with Pseudomonas and Enterobacteriaceae from their own natural flora (Klepzig et al. 1999; 
Tzschoppe 2010). Low numbers (<10 cfu / 25g) of EHEC were still detectable in these 
inoculated food samples after enrichment (Fig. 3). The choice of enrichment medium and 
procedure was found to be important. The presence of an enhancer (Mitomycin C) in the 
growth medium is needed for the best results (data not shown). Further tests on food 
samples contaminated naturally with STEC / EHEC are needed to evaluate the suitability of 
the Rida Quick assay for the routine examination of food samples. 
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